The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031.
Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as alkaline phosphatases, glucose oxidase, and carbonic anhydrase the result can be detected by fluorometry or photometry. Enzyme Immunoassay (EIA) is used as a screening test in the treatment of various infectious diseases such as otavirus, syphilis, Rocky Mountain spotted fever, pernicious anemia, and HIV AIDS. Enzyme Immunoassay (EIA) finds application in different healthcare facilities that includes diagnostic laboratories, hospital, and research laboratories. In addition, Enzyme Immunoassay (EIA) is used in academics, and food industry for different applications.
Increasing incidence of diseases such as infectious diseases and cancer is one of the primary driver associated with the growth of global Enzyme Immunoassay (EIA) Reagents and Kits market. Also, continuous development in biomarkers, cost benefit as compared to other diagnostic tests, and increasing adoption of automated platforms for Enzyme Immunoassay (EIA) has led to increasing demand for Enzyme Immunoassay (EIA) test on the market.Based on the product type, market has been segmented into reagents and kits. In terms of technology, enzyme Immunoassays are further classified into competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA. Based on application, Enzyme Immunoassay (EIA) Reagents and Kits market categorised into Infectious diseases, Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal screening, Hematology, and Others. In term of end-user, the market has been segmented into hospital laboratories, clinical laboratories, pharmaceutical & biotechnology companies, reference laboratories, academics and others.
At regional level, global Enzyme Immunoassay (EIA) Reagents and Kits market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In terms of revenue, North America is major contributor for Enzyme Immunoassay (EIA) test products. Higher adoption of new technologically advanced products and rising awareness for early disease diagnosis propels market growth in the region. Increasing awareness of diseases among peoples that leads to regular check-ups for disease management drives the Enzyme Immunoassay (EIA) test market in North America. The market in North Americas is expected to sustain its growth in the forecast period. North America is followed by Europe which is second largest revenue contributor for global Enzyme Immunoassay (EIA) Reagents and Kits market. The market in Europe is growing steadily because of high prevalence and incidence of disease in the region. Also, the presence of well-established diagnostic laboratories that offers fully automated Enzyme Immunoassay (EIA) test systems with increased efficiency of tests. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities. Many global manufacturers are trying to capture this market.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 19.80 Billion |
|
Revenue Forecast In 2031 |
USD 31.60 Billion |
|
Growth Rate CAGR |
CAGR of 5.5 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Technology, By Applications |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
American Laboratory Products Company, Ltd., Affymetrix, Inc., Thermo Fisher Scientific. Inc., BD Biosciences, bioMérieux SA, Beckman Coulter Inc., Ortho-Clinical Diagnostics, Inc., R&D Systems Inc., QIAGEN, Quidel, Life Technologies Corporation, ZEUS Scientific, Inc, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Technology
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Product Type
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Application
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
